Diamond Information Institute (TCEL) SEC Filing 8-K Material Event for the period ending Tuesday, October 27, 2009

Therapy Cells Inc

CIK: 1429859 Ticker: TCEL

View differences made from one to another to evaluate Therapy Cells Inc's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Therapy Cells Inc.


Assess how Therapy Cells Inc's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Therapy Cells Inc's Definitive Proxy Statement (Form DEF 14A) filed after their 2009 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors


SEC Filing Tools
Ticker: TCEL
CIK: 1429859
Form Type: 8-K Corporate News
Accession Number: 0001255294-09-000763
Submitted to the SEC: Wed Nov 04 2009 5:16:39 PM EST
Accepted by the SEC: Wed Nov 04 2009
Period: Tuesday, October 27, 2009
Industry: Wholesale Jewelry Watches Precious Stones And Metals
  1. Accountant Change
  2. Financial Exhibit

External Resources:
Stock Quote
Social Media

Bookmark the Permalink: